

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.53856403 |
| 2 | response to peptidoglycan (GO:0032494) | 5.06128852 |
| 3 | immunoglobulin mediated immune response (GO:0016064) | 4.41427203 |
| 4 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.38319152 |
| 5 | regulation of mononuclear cell migration (GO:0071675) | 4.37749752 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.37735163 |
| 7 | macrophage activation involved in immune response (GO:0002281) | 4.30005963 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.11995063 |
| 9 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.07924589 |
| 10 | glycosphingolipid catabolic process (GO:0046479) | 4.04857984 |
| 11 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.97253001 |
| 12 | oligosaccharide catabolic process (GO:0009313) | 3.77667202 |
| 13 | T-helper 1 type immune response (GO:0042088) | 3.77403582 |
| 14 | type I interferon signaling pathway (GO:0060337) | 3.76590111 |
| 15 | cellular response to type I interferon (GO:0071357) | 3.76590111 |
| 16 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.76531648 |
| 17 | response to type I interferon (GO:0034340) | 3.71760887 |
| 18 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.69735129 |
| 19 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.68267381 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66379388 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.66379388 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66379388 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66379388 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66379388 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.66379388 |
| 26 | glycolipid catabolic process (GO:0019377) | 3.62710680 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.59905011 |
| 28 | myeloid dendritic cell differentiation (GO:0043011) | 3.59237517 |
| 29 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.57606363 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.52121464 |
| 31 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44114725 |
| 32 | regulation of vitamin metabolic process (GO:0030656) | 3.42124377 |
| 33 | regulation of antigen processing and presentation (GO:0002577) | 3.40945096 |
| 34 | amino sugar catabolic process (GO:0046348) | 3.40509003 |
| 35 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.40125464 |
| 36 | positive regulation of type 2 immune response (GO:0002830) | 3.40005464 |
| 37 | defense response to protozoan (GO:0042832) | 3.36686783 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.34404400 |
| 39 | regulation of chronic inflammatory response (GO:0002676) | 3.32888178 |
| 40 | response to protozoan (GO:0001562) | 3.30910349 |
| 41 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.30617452 |
| 42 | regulation of podosome assembly (GO:0071801) | 3.30316680 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.29703967 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.29703967 |
| 45 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.28548851 |
| 46 | monocyte chemotaxis (GO:0002548) | 3.27485213 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.26766079 |
| 48 | ceramide catabolic process (GO:0046514) | 3.25795537 |
| 49 | positive regulation of heat generation (GO:0031652) | 3.25547272 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25053698 |
| 51 | B cell mediated immunity (GO:0019724) | 3.24453134 |
| 52 | myeloid dendritic cell activation (GO:0001773) | 3.22472705 |
| 53 | germinal center formation (GO:0002467) | 3.22084155 |
| 54 | regulation of chemokine biosynthetic process (GO:0045073) | 3.20927997 |
| 55 | granulocyte activation (GO:0036230) | 3.20831198 |
| 56 | regulation of interleukin-12 production (GO:0032655) | 3.18173188 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15441088 |
| 58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.13201022 |
| 59 | regulation of macrophage chemotaxis (GO:0010758) | 3.09755796 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09604093 |
| 61 | positive regulation of interferon-alpha production (GO:0032727) | 3.08731517 |
| 62 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.06171888 |
| 63 | cellular response to interferon-gamma (GO:0071346) | 3.06009956 |
| 64 | dendritic cell differentiation (GO:0097028) | 3.05665304 |
| 65 | macrophage activation (GO:0042116) | 3.01787058 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 3.00598034 |
| 67 | cellular response to lipopolysaccharide (GO:0071222) | 3.00452769 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 2.99702454 |
| 69 | regulation of fever generation (GO:0031620) | 2.99631262 |
| 70 | detection of other organism (GO:0098543) | 2.99151954 |
| 71 | eosinophil chemotaxis (GO:0048245) | 2.98424522 |
| 72 | response to interferon-gamma (GO:0034341) | 2.96418171 |
| 73 | regulation of cholesterol storage (GO:0010885) | 2.95242287 |
| 74 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95155208 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 2.94903811 |
| 76 | cellular response to molecule of bacterial origin (GO:0071219) | 2.94872640 |
| 77 | cellular extravasation (GO:0045123) | 2.94141555 |
| 78 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.94088486 |
| 79 | response to muramyl dipeptide (GO:0032495) | 2.93818490 |
| 80 | lymphocyte chemotaxis (GO:0048247) | 2.93649659 |
| 81 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.92670243 |
| 82 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.90555937 |
| 83 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.89835069 |
| 84 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89289309 |
| 85 | positive regulation of mast cell degranulation (GO:0043306) | 2.89046181 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89046181 |
| 87 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87874673 |
| 88 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.87257637 |
| 89 | membrane lipid catabolic process (GO:0046466) | 2.86130137 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85308531 |
| 91 | positive regulation of mast cell activation (GO:0033005) | 2.85297768 |
| 92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84806405 |
| 93 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.83954655 |
| 94 | T cell migration (GO:0072678) | 2.83844313 |
| 95 | detection of external biotic stimulus (GO:0098581) | 2.82024553 |
| 96 | response to thyroid hormone (GO:0097066) | 2.80992641 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80596829 |
| 98 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.78869537 |
| 99 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78688969 |
| 100 | regulation of type 2 immune response (GO:0002828) | 2.78468335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69851239 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.77132958 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.96448456 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.24928376 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.88426713 |
| 6 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.81667410 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74395959 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.43542197 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28841160 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21767013 |
| 11 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.02316631 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92707579 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84564185 |
| 14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.68972299 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54289441 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52607333 |
| 17 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.45510029 |
| 18 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.26025573 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22058530 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21002737 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.20962569 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08892855 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.08725347 |
| 24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05307059 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00899836 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96738883 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91801942 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83221788 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81763945 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74390620 |
| 31 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67443528 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66101966 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58096409 |
| 34 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56713613 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55784921 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54000156 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52972864 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52778854 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51329605 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50023351 |
| 41 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47657674 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46605153 |
| 43 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.45764667 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.39606637 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.38214143 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38204489 |
| 47 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38069928 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32841897 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32356889 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30892735 |
| 51 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28482998 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27074489 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25506403 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24821873 |
| 55 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23344961 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23092489 |
| 57 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22939599 |
| 58 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22473463 |
| 59 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.14605953 |
| 60 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13897850 |
| 61 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11348299 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08804560 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07394483 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06862715 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06752550 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05909690 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04856987 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04328645 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.03963774 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03932306 |
| 71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03878932 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03502489 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02455633 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02337460 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01595145 |
| 76 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01175892 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97335603 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97059845 |
| 79 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96581803 |
| 80 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95309760 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94033030 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93239329 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91633236 |
| 84 | MAF_26560356_Chip-Seq_TH2_Human | 0.91606214 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90556815 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87228891 |
| 87 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87090411 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86616385 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84333398 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79663717 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78258888 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 0.77046591 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76039200 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75348817 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75134886 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72817376 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72039566 |
| 98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70255359 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69807224 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68657918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.80306783 |
| 2 | MP0006082_CNS_inflammation | 3.81209333 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.80061047 |
| 4 | MP0003724_increased_susceptibility_to | 3.43907748 |
| 5 | * MP0002148_abnormal_hypersensitivity_rea | 3.37465195 |
| 6 | MP0009785_altered_susceptibility_to | 3.28877434 |
| 7 | MP0003436_decreased_susceptibility_to | 3.26296591 |
| 8 | MP0009840_abnormal_foam_cell | 3.07473632 |
| 9 | * MP0001835_abnormal_antigen_presentation | 3.02664963 |
| 10 | MP0002419_abnormal_innate_immunity | 2.80545956 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.71283705 |
| 12 | MP0004510_myositis | 2.70022496 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.61894704 |
| 14 | MP0005025_abnormal_response_to | 2.60935354 |
| 15 | * MP0005387_immune_system_phenotype | 2.54668820 |
| 16 | * MP0001790_abnormal_immune_system | 2.54668820 |
| 17 | * MP0005671_abnormal_response_to | 2.48019662 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.40646717 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.38575575 |
| 20 | MP0009764_decreased_sensitivity_to | 2.29196990 |
| 21 | * MP0002452_abnormal_antigen_presenting | 2.26043149 |
| 22 | MP0000343_altered_response_to | 2.25016257 |
| 23 | MP0000604_amyloidosis | 2.23356344 |
| 24 | * MP0002723_abnormal_immune_serum | 2.16838681 |
| 25 | MP0003075_altered_response_to | 2.16389324 |
| 26 | * MP0001800_abnormal_humoral_immune | 2.13161821 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.10552157 |
| 28 | MP0000685_abnormal_immune_system | 2.06388781 |
| 29 | MP0001533_abnormal_skeleton_physiology | 2.03816937 |
| 30 | MP0009278_abnormal_bone_marrow | 2.03312940 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.85472900 |
| 32 | MP0005451_abnormal_body_composition | 1.84371391 |
| 33 | * MP0001819_abnormal_immune_cell | 1.82439904 |
| 34 | * MP0002420_abnormal_adaptive_immunity | 1.82199879 |
| 35 | MP0001853_heart_inflammation | 1.81571782 |
| 36 | * MP0001845_abnormal_inflammatory_respons | 1.78747208 |
| 37 | MP0005310_abnormal_salivary_gland | 1.75506115 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.70080884 |
| 39 | MP0003690_abnormal_glial_cell | 1.68057699 |
| 40 | MP0004947_skin_inflammation | 1.67960298 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.66725393 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.62032556 |
| 43 | * MP0008469_abnormal_protein_level | 1.61838915 |
| 44 | MP0002254_reproductive_system_inflammat | 1.61219290 |
| 45 | MP0002405_respiratory_system_inflammati | 1.60704354 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.58267476 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.58267476 |
| 48 | MP0003448_altered_tumor_morphology | 1.49127641 |
| 49 | MP0006054_spinal_hemorrhage | 1.44371966 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.42154464 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.41224716 |
| 52 | MP0008004_abnormal_stomach_pH | 1.40754290 |
| 53 | MP0003195_calcinosis | 1.33671762 |
| 54 | MP0005166_decreased_susceptibility_to | 1.32924165 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.28031777 |
| 56 | * MP0000716_abnormal_immune_system | 1.26402922 |
| 57 | MP0000858_altered_metastatic_potential | 1.20267710 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.13053766 |
| 59 | MP0000920_abnormal_myelination | 1.11158095 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.09629642 |
| 61 | MP0003329_amyloid_beta_deposits | 1.08856801 |
| 62 | MP0002398_abnormal_bone_marrow | 1.00584666 |
| 63 | MP0005164_abnormal_response_to | 0.96654063 |
| 64 | MP0009763_increased_sensitivity_to | 0.96124812 |
| 65 | MP0000689_abnormal_spleen_morphology | 0.94093024 |
| 66 | * MP0002429_abnormal_blood_cell | 0.93655531 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 0.92039596 |
| 68 | MP0003183_abnormal_peptide_metabolism | 0.90918903 |
| 69 | MP0003828_pulmonary_edema | 0.89850951 |
| 70 | MP0004883_abnormal_blood_vessel | 0.87327886 |
| 71 | MP0005390_skeleton_phenotype | 0.83334418 |
| 72 | MP0001663_abnormal_digestive_system | 0.81614739 |
| 73 | MP0002722_abnormal_immune_system | 0.80323462 |
| 74 | MP0008260_abnormal_autophagy | 0.80079188 |
| 75 | MP0005365_abnormal_bile_salt | 0.79090070 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.78065393 |
| 77 | MP0005647_abnormal_sex_gland | 0.77679421 |
| 78 | MP0005165_increased_susceptibility_to | 0.76016150 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.74897791 |
| 80 | MP0001542_abnormal_bone_strength | 0.74833775 |
| 81 | MP0003795_abnormal_bone_structure | 0.73310155 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.72469172 |
| 83 | MP0008874_decreased_physiological_sensi | 0.69518698 |
| 84 | MP0003091_abnormal_cell_migration | 0.69016281 |
| 85 | MP0003646_muscle_fatigue | 0.67320699 |
| 86 | MP0000249_abnormal_blood_vessel | 0.66889673 |
| 87 | MP0002933_joint_inflammation | 0.66796190 |
| 88 | MP0000371_diluted_coat_color | 0.66348016 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.64871850 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.60588758 |
| 91 | MP0010307_abnormal_tumor_latency | 0.58713374 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.58448390 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.57957870 |
| 94 | MP0003634_abnormal_glial_cell | 0.56627979 |
| 95 | MP0002090_abnormal_vision | 0.56395300 |
| 96 | MP0005535_abnormal_body_temperature | 0.52733240 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.52329437 |
| 98 | MP0001851_eye_inflammation | 0.51930080 |
| 99 | MP0003633_abnormal_nervous_system | 0.51726850 |
| 100 | MP0000609_abnormal_liver_physiology | 0.51666070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.81097586 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.81097586 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.81097586 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.44698904 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.31051161 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.11370773 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.07729461 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.68978303 |
| 9 | Disinhibition (HP:0000734) | 4.59617970 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.56779941 |
| 11 | Dysostosis multiplex (HP:0000943) | 4.53685106 |
| 12 | Loss of speech (HP:0002371) | 4.48211616 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.41615354 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.19329349 |
| 15 | Optic neuritis (HP:0100653) | 4.19329349 |
| 16 | Orchitis (HP:0100796) | 4.18606739 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.13328954 |
| 18 | Mutism (HP:0002300) | 4.03175515 |
| 19 | Myositis (HP:0100614) | 3.88896811 |
| 20 | Stomatitis (HP:0010280) | 3.78915032 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.68443771 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.61234841 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.51965223 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.51965223 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.51965223 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.50819753 |
| 27 | Glomerulonephritis (HP:0000099) | 3.42998906 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.30737825 |
| 29 | Mucopolysacchariduria (HP:0008155) | 3.25954890 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.25954890 |
| 31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.12902251 |
| 32 | Nuclear cataract (HP:0100018) | 3.04477950 |
| 33 | Axonal loss (HP:0003447) | 2.97402757 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 2.84200014 |
| 35 | Increased serum ferritin (HP:0003281) | 2.83512884 |
| 36 | Apathy (HP:0000741) | 2.80097300 |
| 37 | Pulmonary infiltrates (HP:0002113) | 2.78028861 |
| 38 | Diminished motivation (HP:0000745) | 2.76827911 |
| 39 | Recurrent skin infections (HP:0001581) | 2.74400312 |
| 40 | Hematochezia (HP:0002573) | 2.72440885 |
| 41 | Purpura (HP:0000979) | 2.71800670 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70823269 |
| 43 | Agnosia (HP:0010524) | 2.70588718 |
| 44 | Obstructive lung disease (HP:0006536) | 2.67426272 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67426272 |
| 46 | Inappropriate behavior (HP:0000719) | 2.67065337 |
| 47 | Hemoptysis (HP:0002105) | 2.63319006 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.62295255 |
| 49 | Amyloidosis (HP:0011034) | 2.59167538 |
| 50 | Myocardial infarction (HP:0001658) | 2.58218125 |
| 51 | Neuronal loss in central nervous system (HP:0002529) | 2.56908288 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.55308835 |
| 53 | Vasculitis (HP:0002633) | 2.54999528 |
| 54 | Complement deficiency (HP:0004431) | 2.53945218 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.52526565 |
| 56 | Metaphyseal irregularity (HP:0003025) | 2.50837519 |
| 57 | Progressive neurologic deterioration (HP:0002344) | 2.49182449 |
| 58 | Increased IgM level (HP:0003496) | 2.42364565 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.41899803 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 2.35369715 |
| 61 | Gangrene (HP:0100758) | 2.31753574 |
| 62 | Petechiae (HP:0000967) | 2.31339048 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.30206893 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.28339653 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.28219916 |
| 66 | Polyneuropathy (HP:0001271) | 2.26492004 |
| 67 | Recurrent viral infections (HP:0004429) | 2.26332836 |
| 68 | Gingivitis (HP:0000230) | 2.25715868 |
| 69 | Meningitis (HP:0001287) | 2.22495715 |
| 70 | Basal ganglia calcification (HP:0002135) | 2.21675833 |
| 71 | T lymphocytopenia (HP:0005403) | 2.18669664 |
| 72 | Malnutrition (HP:0004395) | 2.12285897 |
| 73 | Personality changes (HP:0000751) | 2.10423233 |
| 74 | Encephalitis (HP:0002383) | 2.08553687 |
| 75 | Dementia (HP:0000726) | 2.08181077 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.06556581 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.05221585 |
| 78 | Urticaria (HP:0001025) | 2.03512649 |
| 79 | Memory impairment (HP:0002354) | 2.03408322 |
| 80 | Prolonged neonatal jaundice (HP:0006579) | 2.02250220 |
| 81 | Abnormality of T cell number (HP:0011839) | 2.01400816 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99876170 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99876170 |
| 84 | Abnormality of complement system (HP:0005339) | 1.96786365 |
| 85 | Nausea (HP:0002018) | 1.92508847 |
| 86 | Arterial thrombosis (HP:0004420) | 1.90884342 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 1.90813433 |
| 88 | Pulmonary embolism (HP:0002204) | 1.90350548 |
| 89 | Abnormality of the periventricular white matter (HP:0002518) | 1.90263494 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90208383 |
| 91 | Peripheral demyelination (HP:0011096) | 1.89964602 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 1.88930902 |
| 93 | Retinal atrophy (HP:0001105) | 1.88424215 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 1.87631476 |
| 95 | Premature loss of primary teeth (HP:0006323) | 1.85021106 |
| 96 | Parakeratosis (HP:0001036) | 1.84943648 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.84863040 |
| 98 | Anorexia (HP:0002039) | 1.83702989 |
| 99 | Vertigo (HP:0002321) | 1.83427823 |
| 100 | Pathologic fracture (HP:0002756) | 1.83136606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.43208081 |
| 2 | BLK | 3.61749142 |
| 3 | GRK7 | 3.53871446 |
| 4 | NME2 | 3.30070077 |
| 5 | MAP3K14 | 3.18155596 |
| 6 | RIPK4 | 3.01566406 |
| 7 | TYK2 | 2.84727330 |
| 8 | TBK1 | 2.57102370 |
| 9 | MATK | 2.52635833 |
| 10 | DDR2 | 2.48910305 |
| 11 | TAOK2 | 2.26879021 |
| 12 | IRAK4 | 2.26644711 |
| 13 | FGR | 2.26302427 |
| 14 | MAP4K1 | 2.25589709 |
| 15 | TGFBR2 | 2.24830062 |
| 16 | CSK | 2.14849318 |
| 17 | IKBKE | 2.08060697 |
| 18 | IKBKB | 2.06008127 |
| 19 | MAP3K11 | 1.92421700 |
| 20 | ADRBK2 | 1.90137414 |
| 21 | TXK | 1.77809858 |
| 22 | JAK3 | 1.76984454 |
| 23 | TAOK1 | 1.76475505 |
| 24 | PRPF4B | 1.74683959 |
| 25 | ERN1 | 1.72742156 |
| 26 | ACVR1B | 1.71372682 |
| 27 | MAP3K3 | 1.67498336 |
| 28 | MOS | 1.56826181 |
| 29 | BMPR2 | 1.54704043 |
| 30 | RIPK1 | 1.54327680 |
| 31 | MAP2K3 | 1.48678770 |
| 32 | CDC42BPA | 1.44767764 |
| 33 | CSF1R | 1.44338288 |
| 34 | PIM2 | 1.40967268 |
| 35 | JAK1 | 1.35006847 |
| 36 | ZAP70 | 1.34267967 |
| 37 | SYK | 1.31546822 |
| 38 | LYN | 1.28572908 |
| 39 | MAP3K13 | 1.24207055 |
| 40 | KIT | 1.20660888 |
| 41 | ABL2 | 1.11447117 |
| 42 | CHUK | 1.08898510 |
| 43 | JAK2 | 1.04937388 |
| 44 | IRAK1 | 1.02163669 |
| 45 | FES | 1.00342964 |
| 46 | MAP3K1 | 0.95812757 |
| 47 | IRAK2 | 0.94165508 |
| 48 | MARK3 | 0.93876022 |
| 49 | CAMKK2 | 0.87844444 |
| 50 | HCK | 0.87542002 |
| 51 | LCK | 0.87393946 |
| 52 | BTK | 0.82912440 |
| 53 | TNK2 | 0.80268281 |
| 54 | MAP3K5 | 0.79283312 |
| 55 | MAP2K6 | 0.71736171 |
| 56 | TAOK3 | 0.69860695 |
| 57 | SIK3 | 0.68406884 |
| 58 | TYRO3 | 0.68033436 |
| 59 | TESK2 | 0.67625201 |
| 60 | CAMK1D | 0.64148297 |
| 61 | STK10 | 0.63835053 |
| 62 | DAPK2 | 0.63396370 |
| 63 | CLK1 | 0.51979234 |
| 64 | PDK1 | 0.49895168 |
| 65 | PIM1 | 0.47302845 |
| 66 | CDK6 | 0.47124258 |
| 67 | MAPK4 | 0.46790427 |
| 68 | PDPK1 | 0.46112221 |
| 69 | ABL1 | 0.45616864 |
| 70 | MAPK7 | 0.42696916 |
| 71 | RPS6KC1 | 0.42105957 |
| 72 | RPS6KL1 | 0.42105957 |
| 73 | ITK | 0.40434567 |
| 74 | NEK9 | 0.40228849 |
| 75 | PKN1 | 0.39096134 |
| 76 | DYRK3 | 0.36523605 |
| 77 | RPS6KA6 | 0.36429068 |
| 78 | EPHA3 | 0.34106734 |
| 79 | HIPK2 | 0.33189935 |
| 80 | PDK2 | 0.32862060 |
| 81 | SIK2 | 0.31952069 |
| 82 | TGFBR1 | 0.31429862 |
| 83 | EGFR | 0.31300469 |
| 84 | FYN | 0.30563332 |
| 85 | TESK1 | 0.30485087 |
| 86 | ARAF | 0.29634401 |
| 87 | LATS2 | 0.28739057 |
| 88 | TEC | 0.28603491 |
| 89 | BMX | 0.27823322 |
| 90 | INSR | 0.27157203 |
| 91 | PRKCD | 0.25166656 |
| 92 | RPS6KA2 | 0.23591473 |
| 93 | MAPKAPK2 | 0.23134583 |
| 94 | PRKCQ | 0.19953599 |
| 95 | MAPK12 | 0.18795437 |
| 96 | MARK2 | 0.17760947 |
| 97 | PDGFRB | 0.17642007 |
| 98 | EPHB1 | 0.17517018 |
| 99 | GSK3A | 0.17057306 |
| 100 | PDGFRA | 0.15432921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.29124270 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.19890010 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.95063948 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.95035815 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.91337356 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.89360549 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72478124 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.71588480 |
| 9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.65730181 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58914525 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.47099276 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43610803 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.25975458 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19281071 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18974238 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.08520390 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.05879319 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05792844 |
| 19 | Malaria_Homo sapiens_hsa05144 | 2.05070597 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97982977 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.91494821 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86744609 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.82970543 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79950414 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.79665094 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.70874684 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.66847182 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.58434527 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56566363 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52367958 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.48866715 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47817844 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46650263 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.46209640 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39912656 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35210869 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23109978 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22206847 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19908805 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18774517 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.18247302 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16034996 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.02130450 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02048853 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.00485597 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.99978589 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96008502 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92631435 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91629520 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88789291 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84608731 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82662524 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.80930137 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.80408486 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77463077 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76005290 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.74818775 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.72956226 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.69401845 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69380621 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.66935196 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66920516 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.66803642 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58979045 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58383210 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57952139 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52666002 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51064715 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50796393 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50746507 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46123118 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45523094 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42898467 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40957742 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40874102 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37541893 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35636772 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35229122 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33273357 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33247845 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32961778 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29562910 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29188410 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.28930481 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24319175 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23527903 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.22052372 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16849291 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15913155 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.15376008 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14679367 |
| 92 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14325335 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13936822 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11821455 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.11616177 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11268397 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11136080 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10003141 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07816820 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.04557831 |

